Flash talks on angioedema

Efficacy and safety of lanadelumab in pediatric patients aged 2 to <12 years: subgroup analyses from the SPRING Study

Efficacy and Safety of Oral Administered Bradykinin B2 Receptor Inhibitor PHVS416 in Treatment of Hereditary Angioedema Attacks: Topline Results of RAPIDe-1 Phase 2 Trial

Real-world Burden of Illness in Patients with Hereditary Angioedema Type I and II

Burden of hereditary angioedema: Findings from a multinational patient survey in Argentina and Colombia

Burden of hereditary angioedema: Findings from a multinational survey of caregivers for pediatric and adult patients in Argentina and Colombia

The impact of puberty on onset, frequency, location and severity of attacks in Hereditary Angioedema due to C1-inhibitor deficiency: a survey from the Italian Network for Hereditary and Acquired Angioedema (ITACA)